Klinikum rechts der Isar der TU Munchen

München 81675

1 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumor, Colorectal Cancer, Colorectal Carcinoma, Crohn Disease, Leukemia, Myeloid, Acute, Liver Metastases, Myelodysplastic Syndromes, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed
• FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer — Completed